Insider Transactions in Q1 2024 at Pulmonx Corp (LUNG)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 22
2024
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,184
-0.38%
|
$10,656
$9.36 P/Share
|
Mar 15
2024
|
Steven S. Williamson PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
205,286
+50.0%
|
-
|
Mar 01
2024
|
John Mc Kune INTERIM CFO |
BUY
Grant, award, or other acquisition
|
Direct |
14,400
+18.9%
|
-
|
Mar 01
2024
|
John Mc Kune INTERIM CFO |
SELL
Open market or private sale
|
Direct |
1,078
-0.75%
|
$9,702
$9.06 P/Share
|
Mar 01
2024
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
34,500
+11.17%
|
-
|
Mar 01
2024
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,097
-0.43%
|
$27,873
$9.06 P/Share
|
Mar 01
2024
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
6,954
-0.21%
|
$62,586
$9.06 P/Share
|
Mar 01
2024
|
David Aaron Lehman GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
34,500
+16.08%
|
-
|
Mar 01
2024
|
David Aaron Lehman GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
4,351
-0.97%
|
$39,159
$9.06 P/Share
|
Feb 22
2024
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,184
-0.48%
|
$16,576
$14.2 P/Share
|
Feb 15
2024
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
20,000
-1.75%
|
$280,000
$14.6 P/Share
|
Jan 22
2024
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,184
-0.48%
|
$15,392
$13.13 P/Share
|
Jan 18
2024
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
10,000
-0.87%
|
$120,000
$12.77 P/Share
|